Since its first suggestion as possible option for liver radioembolization treatment, the
therapeutic isotope holmium-166 (166Ho) caught the experts' attention due to its imaging …

Over the years, a broad spectrum of applications of the radionuclide holmium-166 as a
medical isotope has been established. The isotope holmium-166 is attractive as it emits high …

Primary liver tumours (ie hepatocellular carcinoma (HCC) or intrahepatic
cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only …

Background The efficacy of radioembolisation for the treatment of liver tumours depends on
the selective distribution of radioactive microspheres to tumorous tissue. The distribution of …

Purpose As an alternative to technetium-99m-macroaggregated albumin (99m Tc-MAA), a
scout dose of holmium-166 (166 Ho) microspheres can be used prior to 166 Ho …

Radioembolization is an established treatment for chemoresistant and unresectable liver
cancers. Currently, treatment planning is often based on semi-empirical methods, which …

Abstract The IUPAC (International Union of Pure and Applied Chemistry) Periodic Table of
the Elements and Isotopes (IPTEI) was created to familiarize students, teachers, and non …

Recent advances in the field of nanotechnology applications in nuclear medicine offer the
promise of better diagnostic and therapeutic options. In recent years, increasing efforts have …

Radionuclide therapy (RNT) based on the concept of delivering cytotoxic levels of radiation
to disease sites is one of the rapidly growing fields of nuclear medicine. Unlike conventional …

Purpose Radiation pneumonitis is a rare but serious complication of radioembolic therapy of
liver tumours. Estimation of the mean absorbed dose to the lungs based on pretreatment …